KRM Ayurveda IPO
KRM Ayurveda IPO is a book-building IPO of ₹77.49 cr, which is entirely a fresh issue of shares. The price band is set at ₹128 to ₹135 per share and the lot size for an application is 1,000. The IPO is finalized to be open for subscription on January 19, 2026 and closes on January 21, 2026. KRM Ayurveda IPO will list on the NSE SME platform with a tentative listing date fixed as January 27, 2026.
Company Background
KRM Ayurveda Ltd. was founded on September 3, 2019. They are a Delhi-based leading Ayurvedic health care facility. The company is dedicated to changing the “healing intensity” of Ayurveda through a diverse system, with 6 multispecialty hospitals and 5 clinics spanning India. Focusing on individualized care for chronic conditions such as kidney issues and lifestyle diseases, KRM Ayurveda blends classical Panchakarma and Sattvic dietetics with contemporary health. The firm also produces over 300 GMP certified herbal products, as well as providing global teleconsultation services and has within it an established base with over 150,000 customers worldwide focussing on holistic relationships between mind, body and soul.
Operations and Product Range
Facility and Production
This is a professionally managed health care network that has 6 multi-specialty hospitals and 5 clinics located in various parts of India. Its manufacturing arm churns out more than 300 GMP-certified Ayurvedic products ranging from patented medicaments to skin care. With ancient Panchakarma treatment rooms combined with the modern clinical laboratories, these centers provide high-quality and genuine Ayurvedic treatments to over 150,000 patients annually.
Brands and Market Presence
KRM Ayurveda, also known as Karma Ayurveda, has been a familiar brand since 1937 for kidney care and chronic care. The company also sells a consumer line called AyuKarma with more than 300 GMP-certified products, including Shilajit Resin and Arsh Karma. This startup has significant competition in Delhi, Gurugram and Jaipur. They also make their service available to the whole world through teleconsultation and clinics in the UK, UAE and the USA.
Revenue Channels
- • The main source of revenue is IPD and OPD services across 11 facilities.
- • This company sells ayurvedic medicines and wellness products via its dispensaries
- • Tele-consulting services have become a source of revenue for the firm.
Management and Shareholding
Promoters and Shareholding
The company is led by its promoters, Mr. Puneet Dhawan and Mrs. Tanya Dhawan, who maintain a dominant controlling interest. Before the IPO, the promoter group held 92.15% of the company's equity shares. Post-issue, their stake will adjust to accommodate the new public shareholders as the company transitions to being listed on the NSE SME platform.
Board Members
The board members of this company aim to globalise authentic Ayurveda by integrating traditional expertise with modern clinical standards. Members' vision centers on scaling specialized kidney and chronic care through the "Heal in India" initiative. They collectively work for the growth of the company by contributing medical authority, operational excellence and robust corporate governance.
WHAT IS GMP?
GMP (Grey Market Premium) is the difference between the IPO price and the grey market price. It is the premium amount paid for the traded IPO shares. It plays an important role in IPOs as it reflects how the IPO would react on the listing day.
A grey market is a place where shares/stocks are traded before being listed officially on the stock exchange.
KRM Ayurveda IPO GMP
| GMP Date | IPO Price | GMP | Last Updated |
|---|---|---|---|
| - | - | - | - |
**The GMP prices displayed here are solely for informational purposes related to the grey market news. India IPO does not engage in or facilitate grey market trading, nor are these rates (sub2) indicative of any trading activity. We also do not recommend or endorse participation in the grey market.**
KRM Ayurveda IPO Details
| Detail | Description |
|---|---|
| IPO Date | 19 to 21 Jan, 2026 |
| Listing Date | Tue, Jan 27, 2026 |
| Face Value | ₹10 per share |
| Issue Price Band | ₹128 to ₹135 |
| Lot Size | 1,000 Shares |
| Sale Type | Fresh Capital |
| Total Issue Size | 57,40,000 shares (agg. up to ₹77 Cr) |
| Reserved for Market Maker | 4,24,000 shares (agg. up to ₹6 Cr) |
| Fresh Issue(Ex Market Maker) | - |
| Offer for Sale | - |
| Net Offered to Public | 53,16,000 shares (agg. up to ₹72 Cr) |
| Issue Type | Bookbuilding IPO |
| Listing At | NSE SME |
| Share Holding Pre Issue | 1,55,20,800 shares |
| Share Holding Post Issue | 2,12,60,800 shares |
KRM Ayurveda IPO Timeline
| Detail | Description |
|---|---|
| IPO Open Date | Mon, Jan 19, 2026 |
| IPO Close Date | Wed, Jan 21, 2026 |
| Tentative Allotment | Thu, Jan 22, 2026 |
| Initiation of Refunds | Fri, Jan 23, 2026 |
| Credit of Shares to Demat | Fri, Jan 23, 2026 |
| Tentative Listing Date | Tue, Jan 27, 2026 |
KRM Ayurveda IPO Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Individual investors (Retail) (Min) | 2 | 2,000 | ₹2,70,000 |
| Individual investors (Retail) (Max) | 2 | 2,000 | ₹2,70,000 |
| S-HNI (Min) | 3 | 3,000 | ₹4,05,000 |
| S-HNI (Max) | 7 | 7,000 | ₹9,45,000 |
| B-HNI (Min) | 8 | 8,000 | ₹10,80,000 |
KRM Ayurveda IPO Promoter Holding
| Share Holding Pre Issue | Share Holding Post Issue |
|---|---|
| Promoter Holding Pre Issue | 92.15% |
| Promoter Holding Post Issue | [.] |
Competitive Strength:
- • Skilled physicians and certified therapist who ensures quality treatment to the patients.
- • Certified production of Ayurvedic medicine that ensures purity and efficacy.
- • Strong relationships with the customers and repeat clientele.
KRM Ayurveda IPO Financial Information
| Period Ended | Assets | Total Income | Profit After Tax | Net Worth | Reserves and Surplus | Total Borrowing | ||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 31 Mar 2025 | 66.79 | 76.95 | 12.10 | 23.88 | 23.73 | 31.20 | ||||||||||||||||||||||||||||||||||
| 31 Mar 2024 | 43.91 | 67.57 | 3.41 | 11.78 | 11.63 | 23.18 | ||||||||||||||||||||||||||||||||||
| 31 Mar 2023 | 39.48 | 89.38 | 7.60 | 8.37 | 8.22 | 19.87 | ||||||||||||||||||||||||||||||||||
| Amount in ₹ Crore | ||||||||||||||||||||||||||||||||||||||||
Key Performance Indicator
| KPI | Values |
|---|---|
| ROE | 67.86% |
| ROCE | 43.33% |
| Debt/Equity | 1.31 |
| RoNW | 67.86% |
| PAT Margin | 15.80% |
| EBITDA Margin | 24.96% |
| Price to Book Value | 0.08 |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS (Rs) | 7.79 | 5.69 |
| P/E (x) | 17.32 | 23.73 |
KRM Ayurveda IPO Objective
- • Capital expenditure for construction and development for the operational activities.
- • Investment on the purchase of the software and hardware infrastructure
- • Repayment of the loan
- • Funding the working capital requirement of the company
- • General corporate expenses
Conclusion
KRM Ayurveda IPO provides an opportunity to investors to invest in a growing company that has a global reach with all the positive feedback. This company steps into a sector that has been covered for years, but now every person is taking advantage of their ayurvedic medicines and facilities. KRM Ayurveda Ltd. makes consistent growth in the service sector of hospitals, clinics, teleconsultation and ayurvedic products. As of FY25, they have 429 permanent employees in their team.
DRHP:
View DRHPRead more :
Frequently asked Questions (FAQs )
-
What are the KRM Ayurveda IPO issue dates and price band?
The IPO opens on January 19, 2026 and closes on January 21, 2026. The price band is ₹40 to ₹47 per share.
-
Where will the KRM Ayurveda IPO be listed?
The IPO is expected to be listed on the NSE SME platforms.
-
What does the KRM Ayurveda IPO do?
They operate a network of hospitals and clinics across multiple cities in India and tele-consulting services across the world.
-
How much is the KRM Ayurveda IPO size and issue type?
The IPO size is ₹77 cr and the issue type is a Book-building IPO.
-
What is the lot size and minimum investment for the KRM Ayurveda IPO?
The lot size for an application is 1,000. The minimum investment for an individual investor is ₹2,70,000 (2,000 shares).
-
How will the KRM Ayurveda IPO proceeds be used?
IPO proceeds will be used to fulfil the capital requirement of the operational activities, repayment of debt, purchase of infrastructure and the rest will be used for general corporate purposes.
